Laboratorios Duncan – Miriam Martinez, CEO – Argentina
Miriam Martinez, CEO of Laboratorios Duncan and VP of CAPGEN, discusses the challenges her company faces as a generic manufacturer in a branded generic market and their plans for growth…
Savant is aware that health is people’s most valuable asset, and seeks to provide patients with drugs that allow them to enjoy a better quality of life.
At only 20 years of age, it has become a company of international renown that works every day to offer more health and a better life to millions of people, from Argentina to the rest of the world. This achievement has been possible due to the excellence and determination of their staff, made up of more than 350 workers from different areas. Having a production based on international quality standards, extraordinary technological skills, a manufacturing facility equipped with leading-edge technology and strategically located corporate headquarters, they strive to attain a maximum-efficiency industrial and business process.
SAVANT has a model manufacturing plant, located in a 110,000-m² area in the town of El Tío, Córdoba, Argentina, where proprietary drugs in various pharmaceutical forms are produced: solid (tablets, film-coated tablets, and capsules), semi-solid (soft capsules and granules), and liquid (syrups, suspensions). The company also has a dedicated facility for producing antibiotics in solid dosage forms, such as film-coated tablets and extemporaneous compounding with beta-lactam active ingredients and clavulanic acid combinations, and a soft capsule facility with a capacity of 150,000 units per hour, being among the most important plants of these characteristics in the country.
Address
Esteban Echeverria 1050
Vicente Lopez
Buenos Aires B1602ABC
Argentina
(+54) 11 4730 4606
Miriam Martinez, CEO of Laboratorios Duncan and VP of CAPGEN, discusses the challenges her company faces as a generic manufacturer in a branded generic market and their plans for growth…
KPMG’s lead healthcare consultant in Argentina gives an in-depth analysis of the long-term needs and objectives driving change in the industry, the structural issues that need to be overcome before…
The founder and president of Close Up International shares the story of the genesis, evolution, and growth of both his company and the prescription auditing industry, as well as his…
The executive director of Latin America’s largest plasma fractionation plant, a publicly-funded laboratory within the 400 year old National University of Cordoba, discusses the organization’s social responsibility as a provider and leader…
Over the course of a day of unprecedented collaboration, Argentina’s biotech industry came together to discuss the challenges facing their industry in Argentina and the region at BioArgentina 2014, an event…
Nicola Carusoni, PwC’s lead pharmaceutical partner in Buenos Aires, gives an overview of the key trends in the Argentinian pharma industry and discusses the importance of PwC as a partner to the…
Mauro Bono discusses the challenges of building a company from the interior of Argentina, and shares his assessment of the key issues driving and preventing change in the country’s pharmaceutical…
Glenmark’s country manager for Argentina discusses Argentina’s development expertise and how companies like Glenmark can capitalize on it through partnerships and collaborations. How did you become part of Glenmark,…
“We are glad to host, together with ETIF, an event bringing forward pharma technologies to Argentinian patients. We hope this collaboration with ETIF will be the first of many” – Ines…
President of the company, Alberto Alvarez-Saavedra, discusses the company’s transformation into a professional organization, and the strategy which has driven remarkable growth in recent years, and will continue to do so…
On behalf of the chamber of industry that represents research-based pharma and biopharma companies in Argentina, Ernesto Felicio discusses the current challenges facing the industry, and the chambers current agenda…
Long-term strategy is the name of the game for Janssen. Alejandro Smolje, the company’s director of finance for Latin America South, outlines how that strategy is implemented in Argentina and…
See our Cookie Privacy Policy Here
